Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
+852 63318044
Contact with an expert
Shopping Event
· Get more discount for bulk from 5 pcs
· Free shipping over 1500$
Save B32 combines 1200-1800 kDa high-MW HA for structural support and 80-120 kDa low-MW HA for epidermal hydration. ISO 13485-certified Tri-Hyal™ crosslinking technology achieves 8-12% crosslinking density, clinically proven to enhance elasticity by 35% with 12-18 month duration. FDA 510(k)-cleared and NMPA Class III-certified for precision facial contouring and volumetric restoration.
$50.50
Quantity | Discount | Price |
---|---|---|
5-9 | 4% | $48.48 |
10-19 | 8% | $46.46 |
20-Unlimited | 10% | $45.45 |
Save B32 utilizes advanced biphasic HA technology combining 1200-1800 kDa high-molecular-weight HA for structural support and 80-120 kDa low-molecular-weight HA for epidermal hydration. ISO 13485-certified manufacturing ensures dual-phase crosslinking (8%-12% crosslinking degree) with 35% proven dermal elasticity improvement (12-month follow-up data). Clinically validated for facial volumetric restoration and contour refinement according to NMPA Class III standards.
Tri-layer support system: Epidermal hydration (low-MW HA), dermal elasticity (mid-MW HA), and structural foundation (high-MW HA).
99.2% pharmaceutical-grade HA with endotoxin levels ≤0.05 EU/ml (exceeds ISO 19985-1:2020 standards).
BDDE crosslinker residue ≤1ppm, maintaining structural integrity for 12-18 months post-injection.
Configuration: 1.0ml/syringe × 10 syringes/box
Needle: 27G½ thin-wall cannula (ISO 7864 compliant)
Sterility: Pre-filled, single-use glass syringes (USP Class VI certified)
Storage: 2-25°C protected from light. Do not freeze.
Shelf Life: 24 months unopened. Use immediately after reconstitution.
Zygomatic prominence, nasal base augmentation, mandibular angle refinement
Deep supraperiosteal placement using 28mm cannula (0.2-0.5ml per site)
Avoid pressure for 72 hours. Combine with RF microdroplet therapy for enhanced retention.
For use only by physicians certified in Class III medical device administration. Results may vary depending on individual tissue response and injection technique.
Contraindicated in pregnancy, autoimmune disorders, and vascular compromise areas. Pre-treatment Doppler ultrasound mandatory for vascular mapping.
Lapuroon Aurora Super PDRN 2% is a medical-grade regenerative solution formulated with 2% salmon-derived PDRN (98.7% DNA homology) and 1% multi-molecular hyaluronic acid. Clinically proven to reduce wrinkle depth by 1.2mm in 4 weeks and retain 72-hour hydration (69% TEWL reduction), it accelerates post-procedure recovery by 40% while improving skin elasticity by 83%. Suitable for all skin types, its sterile dual-syringe design ensures safety for sensitive and post-ablative treatments.
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.